Market revenue in 2023 | USD 160.0 million |
Market revenue in 2030 | USD 369.8 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.5% in 2023. Horizon Databook has segmented the Mexico stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Over the recent years, Mexico gained attention as a medical tourism destination for stem cell therapies. This is because of the availability of inexpensive treatments attracting patients from the U.S. and Canada.
The Commission Federal para la Protection contra Riesgos Sanitarios (COFEPRIS) regulates the Mexican stem cell market, including registering clinical trials, inspections, and authorizations regarding the usage, storage, and transplant of umbilical cord blood.
In addition, organizations such as Stem Cell Mexico, which provides mesenchymal stem cell therapies for muscle & joint regeneration, cardiovascular diseases, and degenerative diseases, also contribute to market growth in Mexico.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Mexico stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account